Who invested in RayzeBio?
RayzeBio's investors include Wellington Management, Perceptive Advisors, Cormorant Asset Management, Vivo Capital and TCG, and 2 more on record.

United States · Series D startup
Funding summaryUpdated 26 Oct 2026
$160Mraised across 1 round since 2022, from 1 source
Source recordedSEC filing: $168M sold, first sale Aug 2022
From RayzeBio's own website and the SEC filings it signed: 7 on the team.
On the board, as filediAaron KantoffAaron RoystonAlex RosenAngie YouJerel DavisMaha KatabiMary TagliaferriYi Larson
RayzeBio's investors include Wellington Management, Perceptive Advisors, Cormorant Asset Management, Vivo Capital and TCG, and 2 more on record.
RayzeBio has raised $160M across 1 round since 2022.
RayzeBio's most recent round was a Series D of $160M in Sept 2022.
Its most recent round, $160M in Sept 2022, is also its largest on record.
RayzeBio's first round on record, in Sept 2022, was backed by Wellington Management, Perceptive Advisors and Cormorant Asset Management and 4 others.
RayzeBio's latest named round is a Series D, in Sept 2022.
RayzeBio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.